Your browser doesn't support javascript.
loading
GUIP1: a R package for dose escalation strategies in phase I cancer clinical trials.
Dinart, D; Fraisse, J; Tosi, D; Mauguen, A; Touraine, C; Gourgou, S; Le Deley, M C; Bellera, C; Mollevi, C.
Afiliação
  • Dinart D; Inserm CIC1401, Module Epidémiologie Clinique, Institut Bergonié, Bordeaux, France.
  • Fraisse J; Institut du Cancer Montpellier (ICM), Université de Montpellier, Montpellier, France.
  • Tosi D; Institut du Cancer Montpellier (ICM), Université de Montpellier, Montpellier, France.
  • Mauguen A; Memorial Sloan Kettering Cancer Center, New York, USA.
  • Touraine C; Institut du Cancer Montpellier (ICM), Université de Montpellier, Montpellier, France.
  • Gourgou S; Institut du Cancer Montpellier (ICM), Université de Montpellier, Montpellier, France.
  • Le Deley MC; Centre Oscar Lambret, Lille, France.
  • Bellera C; Université Paris-Saclay, Université Paris-Sud, UVSQ, CESP, INSERM, Villejuif, France.
  • Mollevi C; Inserm CIC1401, Module Epidémiologie Clinique, Institut Bergonié, Bordeaux, France.
BMC Med Inform Decis Mak ; 20(1): 134, 2020 06 24.
Article em En | MEDLINE | ID: mdl-32580715
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article